<a href="https://laohu8.com/S/02329">Glory Health</a> Industry Ltd. Reports H1 2025 Net Loss of RMB170 Million Amid Revenue of RMB324.2 Million, Contracted Sales at RMB651.1 Million
Glory Health Industry Ltd. reported its interim results for the six months ended June 30, 2025. The company achieved contracted sales of RMB651.1 million during the period. However, the revenue from property development was reported at RMB182.7 million, indicating a decline from previous figures due to market pressures in the rental sector. Overall, the group's revenue amounted to RMB324.2 million, which is a significant decrease compared to the RMB987.5 million reported in the same period of 2024. The company's gross profit was RMB4.4 million, while it recorded a net loss of RMB170.0 million. The company also announced a strategic shift, planning to transition into the health industry, tapping into its broad market potential. This move signifies a strategic pivot amid a complex market environment. The company's land reserves reached a total gross floor area of 6,387,065 square meters, with 54% of the saleable land reserve located in Beijing.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Glory Health Industry Ltd. published the original content used to generate this news brief on August 29, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.